These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 13022874)

  • 21. TUBERCULOIMMUNITY INDUCED BY KILLED TUBERCLE BACILLI AND THEIR CONSTITUENTS.
    CROWLE AJ
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:27-34. PubMed ID: 14164134
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the virulence of tubercle bacilli; variations in virulence effected by tween 80 and thiosemicarbazone.
    BLOCH H; NOLL H
    J Exp Med; 1953 Jan; 97(1):1-16. PubMed ID: 13022858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airborne immunization against tuberculosis.
    COHN ML; DAVIS CL; MIDDLEBROOK G
    Science; 1958 Nov; 128(3334):1282-3. PubMed ID: 13602798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of T-2 toxin on BCG vaccine efficacy against murine pulmonary tuberculosis.
    Ziprin RL; McMurray DN
    Vet Hum Toxicol; 1989 Jun; 31(3):213-7. PubMed ID: 2741306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental studies on the mechanism of infection and immunity in tuberculosis from the standpoint of analysis of streptomycin dependent tubercle bacilli. 4. Immunization against tuberculosis in guinea pigs with a streptomycin-dependent mutant].
    HASHIMOTO T
    Kekkaku; 1955 Dec; 30(12):707-11. PubMed ID: 13307788
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiments of antituberculous vaccination of mice with killed bacilli].
    SIGNORINI LF; PONS V
    Lotta Tuberc; 1955 Dec; 25(12):838-52. PubMed ID: 13321006
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on tubercle bacillus-monocyte relationship. III. Conditions affecting the action of serum and cells; modification of bacilli in an immune system.
    FONG J; CHIN D; AKIYAMA HJ; ELBERG SS
    J Exp Med; 1959 Jun; 109(6):523-43. PubMed ID: 13654626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM; Pinn ML; Karakousis PC; Hung CF
    Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on fractions of methanol extracts of tubercle bacilli. II. Toxic and allergenic properties of fractions employed as antituberculous vaccine.
    WILLIAMS CA
    J Exp Med; 1960 Mar; 111(3):369-86. PubMed ID: 13785399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunology of tuberculosis].
    Tokunaga T
    Kekkaku; 1989 Feb; 64(2):121-33. PubMed ID: 2499728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study on airborne infection with tubercle bacilli, especially infection with the isoniazid-resistant strain and the relation of BCG immunity].
    SHIMOIDE H; TOYOHARA M
    Kekkaku; 1961 Nov; 36():727-32. PubMed ID: 13911991
    [No Abstract]   [Full Text] [Related]  

  • 32. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. II. Effect of varying the dose of BCG.
    Tuberculosis Program, Public Health Service
    Bull World Health Organ; 1955; 12(1-2):31-45. PubMed ID: 14351967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
    Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
    Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis of rabbits induced by droplet nuclei infection; response to reinfection.
    RATCLIFFE HL; WELLS WF
    J Exp Med; 1948 Jun; 87(6):585-94. PubMed ID: 18858647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
    Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
    BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMMUNIZATION EXPERIMENTS ON RABBITS WITH HEXANE-TREATED, KILLED TUBERCLE BACILLI.
    VAHLNE G
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:47-53. PubMed ID: 14164136
    [No Abstract]   [Full Text] [Related]  

  • 38. INFECTION OF MICE WITH MAMMALIAN TUBERCLE BACILLI GROWN IN TWEEN-ALBUMIN LIQUID MEDIUM.
    Pierce C; Dubos RJ; Middlebrook G
    J Exp Med; 1947 Jul; 86(2):159-74. PubMed ID: 19871664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against tuberculosis with nonliving vaccines. II. Vaccination of guinea pigs with phenol-killed tubercle bacilli.
    WEISS DW; WELLS AQ
    Am Rev Respir Dis; 1960 Apr; 81():518-37. PubMed ID: 13843704
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of treatment with a large dose of isoniazid on an established tuberculous infection in mice.
    ROBSON JM; SULLIVAN FM
    Br J Pharmacol Chemother; 1959 Jun; 14(2):222-8. PubMed ID: 13662578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.